Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 04/14/15 → 06/30/25 |
Funding
- Biogen IDEC: $350,705.00
Natalizumab for Prevention of Post-partum Relapses in patients with Multiple Sclerosis (NAPPREMS)
Project: Research
Project: Research
| Status | Finished |
|---|---|
| Effective start/end date | 04/14/15 → 06/30/25 |